Cambridge, MA-based biotech Genzyme (NASDAQ: [[ticker:GENZ]]) revealed today that it will cut 185 jobs in the Bay State, as an initial implementation of its plan to trim 1,000 jobs across the company by the end of 2011, announced in September. Fifty-eight of the job reductions in Massachusetts will come from not filling open positions, and globally, the firm is cutting about 390 jobs this year. Genzyme said it is targeting $385 million in annual savings by 2012 through the job cuts and other cost-saving steps.
Author: Erin Kutz
Erin Kutz has a background in covering business, politics and general news. She holds a bachelor’s degree in journalism from Boston University. Erin previously worked in the Boston bureau of Reuters, where she wrote articles on the investment management and mutual fund industries. While in college, she researched for USA Today reporter Jayne O’Donnell’s book, Gen Buy: How Tweens, Teens and Twenty-Somethings Are Revolutionizing Retail. She also spent a semester in Washington, DC, reporting Capitol Hill stories as a correspondent for two Connecticut newspapers and interning in the Money section of USA Today, where she assisted with coverage on the retail and small business beats. Erin got her first taste of reporting at Boston University’s independent student newspaper, as a city section reporter and fact checker and editor of the paper’s weekly business section.
View all posts by Erin Kutz
